Michael Schwenkert

Statistics

Publications

Citations

811

H-Index

Active since

2008

Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg(Current)

Universitätsklinikum Erlangen

Christian-Albrechts-Universität zu Kiel

University Medical Center Groningen

University of Lübeck

Michael Schwenkert is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in immunology, cancer immunotherapy, and cancer immunology.

Publications per year

2008–2016

Publications

Targeting of DEC-205 on human dendritic cells results in efficient MHC class II–restricted antigen presentation

Katrin Birkholz, Michael Schwenkert, Christian Kellner et al. · Blood · 2010 · 134 citations · Full text

Life Sciences, Biomedical Sciences, Immunology +14

A recombinant trispecific single‐chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting

Markus Kügler, Christoph Stein, Christian Kellner et al. · British Journal of Haematology · 2010 · 130 citations · Full text

Medicine, Hematology, Immunology +17

A Novel CD19-directed Recombinant Bispecific Antibody Derivative With Enhanced Immune Effector Functions for Human Leukemic Cells

Christian Kellner, Joerg Bruenke, Julia Stieglmaier et al. · Journal of Immunotherapy · 2008 · 77 citations

Pharmacy, Immunology, Oncology +17

Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo

Marco de Bruyn, Anna A. Rybczynska, Yunwei Wei et al. · Molecular Cancer · 2010 · 73 citations · Full text

Medicine, Oncology, Pharmacology +17

Novel conjugates of single‐chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells

Christoph Stein, Christian Kellner, Markus Kügler et al. · British Journal of Haematology · 2010 · 72 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 13